This study aimed to evaluate changes in sleep during the COVID-19 outbreak, and used data-driven approaches to identify distinct profiles of changes in sleep-related behaviors. Demographic, behavioral and psychological factors associated with sleep changes were also investigated.
Frequent nightmares can occur in some patients hospitalized with cardiovascular diseases and are associated with depression, anxiety, and insomnia.
Cognitive behavioral therapy is the first line treatment for insomnia, but studies have reported potential negative effects. This review aims to understand the extent to which adverse events are monitored for and reported in trial literature.
Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.
Patients with fibromyalgia suffer from chronic pain, which limits physical activity and is associated with disturbed sleep. However, the relationship between physical activity, pain, and sleep is unclear.
For individuals who have recovered from the acute phase of COVID-19, postviral fatigue is prevalent and is not associated with COVID-19 severity.
This study addresses possible consequences of the COVID-19 crisis and home confinement on maternal anxiety, maternal insomnia, and maternal reports of sleep problems among children aged 6–72 months.
Four distinct physical activity profiles are detectable using activity monitoring among adults with arthritis.
Both insufficient and excessive sleep are associated with faster cognitive decline compared with sleeping approximately 7 hours per night.
Serotonergic antidepressants are effective for sleep disturbances in perimenopausal and postmenopausal women even without major depressive disorder.
